Andrea Martinuzzi

Summary

Country: Italy

Publications

  1. ncbi Phenotype modulators in myophosphorylase deficiency
    Andrea Martinuzzi
    E Medea Scientific Institute, Conegliano Research Centre, Conegliano, Italy
    Ann Neurol 53:497-502. 2003
  2. ncbi Randomized, placebo-controlled, double-blind pilot trial of ramipril in McArdle's disease
    Andrea Martinuzzi
    E Medea Scientific Institute, Conegliano Research Centre, Via Costa Alta 37, 31015 Conegliano TV, Italy
    Muscle Nerve 37:350-7. 2008
  3. ncbi Disseminating the WHO International Classification of Functioning Health and Disability (ICF) in the Veneto region of Italy
    Andrea Martinuzzi
    E Medea Scientific Institute, Conegliano Research Centre, Conegliano, Italy
    Disabil Rehabil 30:71-80. 2008
  4. ncbi The International Classification of Functioning Disability and Health, version for children and youth as a roadmap for projecting and programming rehabilitation in a neuropaediatric hospital unit
    Andrea Martinuzzi
    E Medea Scientific Institute, Conegliano Pieve di Soligo Research Centre, Via Costa Alta 37, IT 31015 Conegliano, Italy
    J Rehabil Med 42:49-55. 2010
  5. ncbi Projecting and programming rehabilitation based on ICF-CY format in a neuropediatric hospital unit
    Anna Maria Salghetti
    E Medea Scientific Institute, Conegliano Pieve di Soligo Research Centre, Conegliano, Italy
    Disabil Rehabil 31:S55-60. 2009
  6. ncbi Children with disability at school: the application of ICF-CY in the Veneto region
    Gianni De Polo
    E Medea Scientific Institute, Conegliano, Italy
    Disabil Rehabil 31:S67-73. 2009
  7. ncbi Functioning and disability in patients with Angelman syndrome: utility of the International Classification of functioning disability and health, children and youth adaptation framework
    Paolo Bonanni
    E Medea Scientific Institute, Conegliano Pieve di Soligo Research Centre, Conegliano, Italy
    Disabil Rehabil 31:S121-7. 2009
  8. ncbi International Classification of Functioning, Disability and Health in a cohort of children with cognitive, motor, and complex disabilities
    Mariamalia Battaglia
    E. Medea Scientific Institute, Conegliano Research Centre, Via Costa Alta 37, 31015 Conegliano, Treviso, Italy
    Dev Med Child Neurol 46:98-106. 2004
  9. ncbi The dystonic child treated with deep brain stimulation: ICF reading of a high-tech approach
    Elisa Petacchi
    E Medea Scientific Institute, Conegliano Pieve di Soligo Research Centre, Conegliano, Italy
    Disabil Rehabil 31:S159-69. 2009
  10. ncbi McArdle disease: the mutation spectrum of PYGM in a large Italian cohort
    Claudio Bruno
    Neuromuscular Disease Unit, Department of Pediatrics, University of Genova, Giannina Gaslini Institute, Genova, Italy
    Hum Mutat 27:718. 2006

Collaborators

  • Carlo Francescutti
  • Matilde Leonardi
  • Alberto Raggi
  • Corrado Angelini
  • Gabriele Siciliano
  • Graham J Kemp
  • Marina Fanin
  • P Bonanni
  • R Lodi
  • L Merlini
  • Claudio Bruno
  • Maria Bonsignore
  • G de Girolamo
  • M Nobile
  • Alessandra Renieri
  • M Mancuso
  • Massimo Pandolfo
  • U Nocentini
  • Cecilia Marino
  • Nereo Bresolin
  • Chris Panzeri
  • Elisa Petacchi
  • Anna Maria Salghetti
  • Gianni De Polo
  • Alessia Arnoldi
  • Maria Teresa Bassi
  • Francesca Crippa
  • Sara Galbiati
  • Andrea Daga
  • Genny Orso
  • Mara Buffoni
  • Monica Pradal
  • Gianfranco Cafforio
  • Pierluigi Longatti
  • Giovanni Meola
  • Giacomo Pietro Comi
  • Alessandra Tonelli
  • Francesca Redaelli
  • Maria Grazia D'Angelo
  • Emanuela Russo
  • Alessandra Frigerio
  • Antonio Toscano
  • Mariamalia Battaglia
  • Evan Fertig
  • Maria Teresa Armellin
  • Marco Gubernale
  • Ornella Moret
  • Silvana Betto
  • Sonia Bortolot
  • Dina Facchin
  • Manuela Sironi
  • Claudia Crimella
  • Domenico D'Avella
  • Consiglia Pacelli
  • Alessandro Fiorindi
  • Anna Carla Turconi
  • Nicola Morelli
  • Uberto Pozzoli
  • Francesco Crippa
  • Selina Piazza
  • Alberto Feletti
  • Gaetano Villani
  • Rosanna Calabrese
  • M hammed Aguennouz
  • Sara Bonato
  • Pierluigi Morosini
  • Antonio Trabacca
  • Gabriella Polidori
  • Giacomo P Comi
  • Andreina Bordoni
  • Olimpia Musumeci
  • Pina Cavolina
  • Christopher C Miller
  • Andrea Tullini
  • Alex Papadimitriou
  • Paola Rucci
  • Roberto Giorda
  • Massimo Molteni
  • Emilio Clementi
  • Anastasia Garufi
  • Costanza Lamperti
  • Clara De Palma
  • Massimo Ammaniti
  • Loredana Lucarelli
  • Elizabeth L Tudor
  • Cinzia Baschirotto
  • Carmelo Rodolico
  • Alessandro Prelle
  • Mauro Walder
  • Giovanni Vazza

Detail Information

Publications20

  1. ncbi Phenotype modulators in myophosphorylase deficiency
    Andrea Martinuzzi
    E Medea Scientific Institute, Conegliano Research Centre, Conegliano, Italy
    Ann Neurol 53:497-502. 2003
    ..We show that ACE insertion/deletion polymorphism may play a significant role as phenotype modulator in McArdle's disease...
  2. ncbi Randomized, placebo-controlled, double-blind pilot trial of ramipril in McArdle's disease
    Andrea Martinuzzi
    E Medea Scientific Institute, Conegliano Research Centre, Via Costa Alta 37, 31015 Conegliano TV, Italy
    Muscle Nerve 37:350-7. 2008
    ..Treatment with ramipril improves disability and modifies exercise physiology only in D/D patients, raising the possibility of a differential haplotype-linked sensitivity to the treatment...
  3. ncbi Disseminating the WHO International Classification of Functioning Health and Disability (ICF) in the Veneto region of Italy
    Andrea Martinuzzi
    E Medea Scientific Institute, Conegliano Research Centre, Conegliano, Italy
    Disabil Rehabil 30:71-80. 2008
    ....
  4. ncbi The International Classification of Functioning Disability and Health, version for children and youth as a roadmap for projecting and programming rehabilitation in a neuropaediatric hospital unit
    Andrea Martinuzzi
    E Medea Scientific Institute, Conegliano Pieve di Soligo Research Centre, Via Costa Alta 37, IT 31015 Conegliano, Italy
    J Rehabil Med 42:49-55. 2010
    ....
  5. ncbi Projecting and programming rehabilitation based on ICF-CY format in a neuropediatric hospital unit
    Anna Maria Salghetti
    E Medea Scientific Institute, Conegliano Pieve di Soligo Research Centre, Conegliano, Italy
    Disabil Rehabil 31:S55-60. 2009
    ..To follow-up the impact of a format based upon the International Classification of Functioning Disability and Health, version for children and youth (ICF-CY) as a roadmap for in-hospital pediatric neuro-rehabilitation...
  6. ncbi Children with disability at school: the application of ICF-CY in the Veneto region
    Gianni De Polo
    E Medea Scientific Institute, Conegliano, Italy
    Disabil Rehabil 31:S67-73. 2009
    ....
  7. ncbi Functioning and disability in patients with Angelman syndrome: utility of the International Classification of functioning disability and health, children and youth adaptation framework
    Paolo Bonanni
    E Medea Scientific Institute, Conegliano Pieve di Soligo Research Centre, Conegliano, Italy
    Disabil Rehabil 31:S121-7. 2009
    ..The aim of the study is to test whether the ICF-CY framework is effectively able to capture the various dimensions of health in AS...
  8. ncbi International Classification of Functioning, Disability and Health in a cohort of children with cognitive, motor, and complex disabilities
    Mariamalia Battaglia
    E. Medea Scientific Institute, Conegliano Research Centre, Via Costa Alta 37, 31015 Conegliano, Treviso, Italy
    Dev Med Child Neurol 46:98-106. 2004
    ..Our study, although acknowledging the universal application of the ICF, and the ICF's value as a clinical tool, calls for its specific adaptation to accommodate better the peculiarities of child functioning and disability...
  9. ncbi The dystonic child treated with deep brain stimulation: ICF reading of a high-tech approach
    Elisa Petacchi
    E Medea Scientific Institute, Conegliano Pieve di Soligo Research Centre, Conegliano, Italy
    Disabil Rehabil 31:S159-69. 2009
    ....
  10. ncbi McArdle disease: the mutation spectrum of PYGM in a large Italian cohort
    Claudio Bruno
    Neuromuscular Disease Unit, Department of Pediatrics, University of Genova, Giannina Gaslini Institute, Genova, Italy
    Hum Mutat 27:718. 2006
    ..R50X) accounted for about 43% of alleles in our cohort and that no population-related mutations are clearly identified in Italian patients...
  11. ncbi New mutations in TK2 gene associated with mitochondrial DNA depletion
    Sara Galbiati
    Centro Dino Ferrari, Department of Neurological Sciences, University of Milan, I R C C S Ospedale Maggiore Policlinico, Milano, Italy
    Pediatr Neurol 34:177-85. 2006
    ....
  12. ncbi Training on the International Classification of Functioning, Disability and Health (ICF): the ICF-DIN Basic and the ICF-DIN Advanced Course developed by the Disability Italian Network
    Matilde Leonardi
    C Besta Italian National Neurological Institute, Via Celoria 11, I 20133 Milan, Italy
    J Headache Pain 6:159-64. 2005
    ..The ICF-DIN courses already carried out in Italy show that this teaching methodology teaches how to avoid incomplete applications, simplification and misunderstanding of ICF's complexity...
  13. ncbi The first Italian family with evidence of pyramidal impairment as phenotypic manifestation of Silver syndrome BSCL2 gene mutation
    Gianfranco Cafforio
    Department of Neuroscience O U of Neurology, S Chiara Hospital, University of Pisa, Pisa, Italy
    Neurol Sci 29:189-91. 2008
    ..This family confirms the clinical heterogeneity associated with this specific mutation. Moreover, this is the first report in which neuroimaging seems to confirm the pyramidal alterations in dHMN associated to SPG17...
  14. ncbi Endoscopic anatomy of the fourth ventricle
    Pierluigi Longatti
    Department of Neurosurgery, Treviso Hospital, Italy
    J Neurosurg 109:530-5. 2008
    ....
  15. ncbi A clinical, genetic, and biochemical characterization of SPG7 mutations in a large cohort of patients with hereditary spastic paraplegia
    Alessia Arnoldi
    Laboratory of Molecular Biology, Scientific Institute E Medea, Bosisio Parini, Italy
    Hum Mutat 29:522-31. 2008
    ..Overall, our data confirm that SPG7 point mutations are rare causes of HSP, in both sporadic and familial forms, while underlying the puzzling and intriguing aspects of histological and biochemical consequences of paraplegin loss...
  16. ncbi Novel LGI1 mutation in a family with autosomal dominant partial epilepsy with auditory features
    Evan Fertig
    Department of Neurology, Yale University School of Medicine, New Haven, CT, USA
    Neurology 60:1687-90. 2003
    ..This report suggests that this domain may participate in the development of the ADPEAF phenotype...
  17. ncbi Eight novel mutations in SPG4 in a large sample of patients with hereditary spastic paraplegia
    Francesca Crippa
    Laboratory of Molecular Biology, IRCCS Eugenio Medea, Via D L Monza 20, 23842 Bosisio Parini, Lecco, Italy
    Arch Neurol 63:750-5. 2006
    ..Mutations in the SPG4 gene, which encodes spastin protein, are responsible for up to 45% of autosomal dominant cases...
  18. ncbi The Italian preadolescent mental health project (PrISMA): rationale and methods
    Alessandra Frigerio
    Child Psychiatry Unit, Scientific Institute E Medea, Bosisio Parini LC, Italy
    Int J Methods Psychiatr Res 15:22-35. 2006
    ..The findings of this study are expected to allow an adequate planning of interventions for the prevention and the treatment of mental disorders in preadolescence as well as efficient health services...
  19. ncbi The first ALS2 missense mutation associated with JPLS reveals new aspects of alsin biological function
    Chris Panzeri
    IRCCS E Medea, Laboratory of Molecular Biology, Bosisio Parini Lecco, Italy
    Brain 129:1710-9. 2006
    ..Finally, the phenotype-genotype correlation in our patient, in view of all other ALS2 mutant cases reported previously, suggests a functional interplay of long and short forms of alsin in relation to disease onset and progression...
  20. ncbi Disease-related phenotypes in a Drosophila model of hereditary spastic paraplegia are ameliorated by treatment with vinblastine
    Genny Orso
    Dulbecco Telethon Institute and Department of Pharmacology, University of Padova, Padova, Italy
    J Clin Invest 115:3026-34. 2005
    ....